1. Home
  2. BLRX vs OMH Comparison

BLRX vs OMH Comparison

Compare BLRX & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • OMH
  • Stock Information
  • Founded
  • BLRX 2003
  • OMH 2015
  • Country
  • BLRX Israel
  • OMH Singapore
  • Employees
  • BLRX N/A
  • OMH N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • BLRX Health Care
  • OMH Finance
  • Exchange
  • BLRX Nasdaq
  • OMH Nasdaq
  • Market Cap
  • BLRX 15.3M
  • OMH 13.6M
  • IPO Year
  • BLRX 2011
  • OMH 2023
  • Fundamental
  • Price
  • BLRX $4.53
  • OMH $1.38
  • Analyst Decision
  • BLRX Strong Buy
  • OMH Hold
  • Analyst Count
  • BLRX 2
  • OMH 1
  • Target Price
  • BLRX $19.00
  • OMH N/A
  • AVG Volume (30 Days)
  • BLRX 217.2K
  • OMH 5.5M
  • Earning Date
  • BLRX 08-14-2025
  • OMH 07-11-2025
  • Dividend Yield
  • BLRX N/A
  • OMH N/A
  • EPS Growth
  • BLRX N/A
  • OMH N/A
  • EPS
  • BLRX N/A
  • OMH N/A
  • Revenue
  • BLRX $22,340,000.00
  • OMH $7,976,578.00
  • Revenue This Year
  • BLRX N/A
  • OMH $28.40
  • Revenue Next Year
  • BLRX N/A
  • OMH $23.07
  • P/E Ratio
  • BLRX N/A
  • OMH N/A
  • Revenue Growth
  • BLRX 91.68
  • OMH 117.53
  • 52 Week Low
  • BLRX $2.30
  • OMH $0.59
  • 52 Week High
  • BLRX $35.60
  • OMH $6.20
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 52.05
  • OMH 44.19
  • Support Level
  • BLRX $4.20
  • OMH $1.35
  • Resistance Level
  • BLRX $4.62
  • OMH $1.58
  • Average True Range (ATR)
  • BLRX 0.43
  • OMH 0.15
  • MACD
  • BLRX -0.09
  • OMH 0.02
  • Stochastic Oscillator
  • BLRX 34.42
  • OMH 16.36

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: